MedTrace Logo

NSAIDs Treatment in Children With Pleuropneumonia

NCT01586299 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2014-11-14

No results posted yet for this study

Summary

The purpose of this study is to evaluate the influence of routine NSAIDs treatment for hospitalized children with pleuropneumonia in comparison with acetominophen treatment (all in conjunction with adequate antibiotic therapy).

Conditions

  • Pleuro-pneumonia

Interventions

DRUG

Ibuprofen

10 mg/kg every 8 hours until 24 hours after resolution of fever

DRUG

Acetaminophen

15 mg/kg every 6 hours until 24 hours after resolution of fever

Sponsors & Collaborators

  • Rabin Medical Center

    lead OTHER

Principal Investigators

  • havatzelet yarden-bilavsky, MD · schneider children MC of Israel

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • Israel

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01586299 on ClinicalTrials.gov